Oppenheimer & CO Inc Ptc Therapeutics, Inc. Transaction History

Oppenheimer & CO Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 31, 2019	SELL	$33.82 - $48.17 $260,346 - $370,812	-7,698 Closed	0 $0
Q2 2019 Aug 09, 2019	SELL	$35.42 - $45.0 $31,878 - $40,500	-900 Reduced 10.47%	7,698 $346,000
Q1 2019 Apr 24, 2019	SELL	$28.09 - $39.49 $98,315 - $138,215	-3,500 Reduced 28.93%	8,598 $323,000
Q4 2018 Jan 29, 2019	SELL	$29.83 - $46.51 $74,575 - $116,275	-2,500 Reduced 17.13%	12,098 $416,000
Q3 2018 Oct 26, 2018	SELL	$33.9 - $47.77 $16,950 - $23,885	-500 Reduced 3.31%	14,598 $686,000

Q2 2018 Aug 10, 2018	SELL	$25.7 - $47.88 $48,830 - $90,972	-1,900 Reduced 11.18%	15,098 $509,000
Q1 2018 May 01, 2018	SELL	$17.46 - $32.59 $8,642 - $16,132	-495 Reduced 2.83%	16,998 $460,000
Q4 2017 Feb 07, 2018	BUY	$15.14 - $20.89 $36,336 - $50,136	2,400 Added 15.9%	17,493 $292,000
Q3 2017 Nov 09, 2017	BUY	$16.81 - $21.61 $253,713 - $326,159	15,093	15,093 $302,000

325

83.2M

811K

207K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $5.39B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Oppenheimer & CO Inc with notifications on news.